GSK Consumer Healthcare

Brokerage: Nomura | Rating: Neutral | Target: Cut to Rs 5,271

The brokerage said that the target price was cut due to slowing rural growth, GST and demonetization. It also cut FY18-19 earnings estimates by 7-8 percent and is building in a revenue growth of 10.3 percent for FY18.

Best services for customers with full technical support make your Financial Trading more easy click here to subscribe us for free >>http://ripplesadvisory.com/nifty-future.php

Larsen & Toubro

Brokerage: CLSA | Rating: Buy | Target: Rs 1,400

CLSA said that the company is set to win USD 1.8 billion order from harbor link and coastal road order is likely to be next. The brokerage house observed that the company has a credible strategy to improve growth and RoE.

DLF

Brokerage: Bank of America Merrill Lynch | Rating: Initiate with underperform | Target: Rs 163

The company expects sales expected to remain weak over FY17-20 as it plans to launch projects only after obtaining occupancy certificate. This, it added, could lead to negative free cash flows of Rs 2,000 crore over FY18-20.

MRF

Brokerage: Deutsche Bank Markets Research | Rating: Initiate with buy | Target: Rs 80,000

The global broking firm sees an upside of 25 percent on the stock and said that the stock commands a leadership position across key tyre segments. It also expects EPS to grow at CAGR of 16% over FY17-20, while volumes could grow 10 percent over FY17-20.

Godrej Properties

Brokerage: Bank of America Merrill Lynch | Rating: Initiate buy | Target: Rs 756

Prestige Estates

Brokerage: Bank of America Merrill Lynch | Rating: Initiate with buy | Target: Rs 334

Oberoi

Brokerage: Bank of America Merrill Lynch | Rating: Initiates coverage with Neutral | Target: Rs 432

Ceat

Brokerage: Deutsche Bank Markets Research | Rating: Initiate with buy | Target: Rs 2,150

Apollo Tyres

Brokerage: Deutsche Bank Markets Research | Rating: Buy | Target: Raised to Rs 325